Viking Therapeutics (0VQA.L) Stock Price
$28.42 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Viking Therapeutics, AI stock picks, stock alerts and much more.
0VQA.L AI Stock Analysis
AI stock analysis for 0VQA.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Viking Therapeutics (0VQA.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Viking Therapeutics (0VQA.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Viking Therapeutics (0VQA.L), currently trading at $28.42, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0VQA.L
-
Viking Therapeutics, Inc.
-
Symbol
0VQA.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
3.2B
Similar Stocks
 |
Waters Corporation 0LTI.L |
$361.3 1.6% |
6 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$504.7 0.5% |
6 |
 |
Neurocrine Biosciences 0K6R.L |
$112.5 2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$5.68 1.5% |
3 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.12 3.1% |
3 |
News
0VQA.L Alternative Data
Web Traffic
Viking Therapeutics receives an estimated 56994 monthly visitors to vikingtherapeutics.com.
-
Web Traffic
56994
-
Change from Previous Month
6.1%
-
3 Month Change
15.3%
-
YoY Change
15.3%
News Mentions
Viking Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Twitter Followers
Viking Therapeutics has 4,225 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.8% over the last month.
-
Twitter Followers
4225
-
Daily Change
0%
-
1 Month Change
2.8%
-
3 Month Change
10.5%
LinkedIn Followers
9,623 are following Viking Therapeutics on LinkedIn, up by 4% over the last month.
-
LinkedIn Followers
9623
-
Daily Change
0.1%
-
1 Month Change
4%
-
3 Month Change
11.5%
Job Postings
Viking Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Viking Therapeutics has 39 employees, up by 11.4% over the last month.
-
LinkedIn Employees
39
-
Daily Change
0%
-
1 Month Change
11.4%
-
3 Month Change
14.7%
Reddit Mentions
Viking Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
0VQA.L Financials
0VQA.L Key Metrics
-
Total Revenue
$0
-
Net Income
-$35.4M
-
Earnings per Share
-$0.32
-
Free cash flow
-$31.2M
-
EBITDA
-$46.1M
-
EBITDA Ratio
0
-
Total Assets
$908.3M
0VQA.L 2-year Revenue & Income
0VQA.L 2-year Free Cash Flow
0VQA.L Technicals
0VQA.L SMA
0VQA.L RSI
FAQ
What's the current price of Viking Therapeutics (0VQA.L) Stock?
The price of an Viking Therapeutics (0VQA.L) share is $28.42.
What's the market cap of Viking Therapeutics?
The current market cap of Viking Therapeutics is 3.2B.
Should I buy or sell 0VQA.L?
Multiple alternative data signals suggest that Viking Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Viking Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Viking Therapeutics stock. The bullish indicators suggest that Viking Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Viking Therapeutics (0VQA.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Viking Therapeutics stock, given the bullish outlook.
What are some stocks similar to Viking Therapeutics (0VQA.L) that investors often compare it to?
Viking Therapeutics (0VQA.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..
What is the forecast for Viking Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Viking Therapeutics' stock price to be around $30.42 in 2026. Starting from the current price of $28.42, this represents a 7% change in price, indicating a bullish outlook for the stock.
How to buy Viking Therapeutics (0VQA.L) Stock?
Viking Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Viking Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.